help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chatterton, R. T.
Right arrow Articles by Hudgens, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatterton, R. T., Jr.
Right arrow Articles by Hudgens, G. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 8 2503-2509
Copyright © 1997 by The Endocrine Society


Clinical Studies

Hormonal Responses to Psychological Stress in Men Preparing for Skydiving1

Robert T. Chatterton, Jr., Kirsten M. Vogelsong, Yu-cai Lu and Gerald A. Hudgens

Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois 60611; and the U.S. Army Research Laboratory, Aberdeen Proving Ground, Aberdeen, Maryland 21005

Address all correspondence and requests for reprints to: Robert T. Chatterton, Ph.D., Department of Obstetrics and Gynecology, Northwestern University Medical School, 333 East Superior Street, Chicago, Illinois 60611.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The purpose of the study was to examine the relationship between the hormonal and psychological responses of young men about to engage in a potentially life-threatening event. Subjects were recruited to take their first skydiving jump. The scores on questionnaires designed to assess anxiety were not significantly increased at 0800 h on the morning before the jump by comparison with scores obtained from the same subjects 3–5 days previously. However, a psychological instrument for rating of events indicated significantly increased intensity, and sympathetic nervous system activity, as measured by the salivary amylase response, was increased over self-control values. Salivary cortisol and testosterone levels were significantly lower on the morning of the jump than self-control values and values in control subjects determined at the same time of day. However, plasma LH was not suppressed. The anxiety and stress measures as well as the rating of events rose to high levels just before the jump. With the exception of testosterone, which remained low, serum cortisol, PRL, and GH all increased greatly subsequent to the rise in psychological measures, reached peak values before or shortly after landing, and declined significantly within the next hour. Anxiety and subjective stress scores declined to those of the self-control values within 15 min after landing, but the rating of events scale remained significantly elevated. In summary, reported anxiety associated with a purely psychological stressor was suppressed until within a few hours preceding the event, but was preceded by an increase in sympathetic nervous system activity and suppression of plasma cortisol and salivary testosterone levels. The event itself was associated with a reversal of the cortisol decline; other stress-associated hormones increased, but salivary testosterone remained low.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
PREVIOUS studies have demonstrated that parachuting or skydiving is a most ideal psychological stressor for experimental studies. Subjects are frequently willing to subject themselves to the risk of injury for the thrill of adventure. By the same token, inferences to a general population are limited by the fact that the volunteer population is likely to represent thrill seekers and underrepresent more cautious individuals. Nevertheless, no difference was found between the volunteers and a control group in Zuckerman’s Sensation Seeking Scale (SSS) (1).

In the studies of stress responses to parachuting reported in the monograph by Levine et al. (2), a primary focus was on modification of the physiological effects of parachute jumping after successive experiences. That is, those investigators sought to evaluate the coping ability of the participants. In the present study our primary interest was in the period of time preceding the jump, the time when psychological forces alone are acting. Other studies of this type (3, 4, 5, 6, 7, 8) have not compared the period immediately before the stress event with hormone levels and psychological measures determined in control subjects. Although parachute jumping has been considered primarily a psychological stressor, the acceleration forces involved are a physical stressor that may alter blood flow within the body and cause substantial increases in plasma cortisol and catecholamine levels. Centrifugal forces have been shown to produce 2- to 3-fold increases in plasma cortisol and catecholamines (9).

Anticipatory coping responses may occur before a major inevitable stressor, such as a surgical procedure (10) or aircraft landings at sea (11), particularly before the actual physical preparation for the event (10) or when the outcome is in another person’s hands (11). In the present study naive volunteers were informed that they would be skydiving with an instructor; however, the degree of control that was theirs was not made known until the prejump instruction. Psychological perception of stress was assessed at intervals before and after the jump, and hormone levels in blood and saliva were measured to monitor physiological responses.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

Subjects were male students and staff recruited from the Northwestern University Medical Center in Chicago. The average age of the 26 volunteers was 26.4 yr (range, 22–36 yr). None had previously parachuted or skydived from an airplane. All had had a physical examination within the year before they volunteered, and all were in good health. All subjects completed the trait and state portions of the State-Trait Anxiety Inventory (STAI) (12) and the Multiple Affect Adjective Checklist–Revised (MAACL-R) (13) and provided single blood and saliva samples at a mean time of 1400 h, 3–5 days before the day of the skydive was scheduled. The study was approved by the institutional review board of Northwestern University, and all subjects signed the informed consent form before participation in the study.

On any given day between one and three subjects participated in the study. Recruits had an indwelling catheter with a heparin lock inserted into an antecubital vein before leaving the medical center at 0745 h for a 45-min ride to the skydiving school. On the way to the site, four samples of heparinized blood and saliva were collected from the volunteers, one sample every 15 min. Saliva flow was stimulated by chewing sugarless gum, and saliva was collected by expectoration into a 30-mL plastic beaker and stored on ice. Additional samples were obtained after the 1-h classroom instruction, just before entering the airplane (time zero). After an approximately 30-min flight, the subjects jumped with an instructor. The altitude of the plane at the time of the jump was 9,000–10,000 ft; the student and instructor were attached by a harness with the instructor behind the student, and they experienced free fall for 4,000–5000 ft before the parachute was opened. It was the student’s responsibility to pull the rip cord to open the parachute. Immediately after the subjects touched the ground, a blood sample was drawn from the indwelling catheter, and saliva was collected. Additional blood and saliva samples were obtained at 15-min intervals for the next 45 min. Samples were placed in sealed containers and kept on ice until being returned to the medical center in the afternoon.

The state portions of the psychological instruments were administered to the volunteers between the first and second blood and saliva collections on the morning of the jump (0800–0815 h), just before boarding the plane (1230 h), and after returning to the skydiving center after the jump (1345–1400 h) to assess their perceptions of anxiety, hostility, depression, and overall stress levels.

Control subjects were also recruited from the medical center. Blood was collected from an indwelling catheter, and saliva was collected in the same manner as in the subjects who volunteered for the skydiving lesson. The timing of the three samples was calculated to correspond to 1) the mean time of the fourth sample of the morning, 2) the sample taken just before subjects entered the plane, and 3) the last sample of the day. Subjects read, watched television, or walked in the area. The average age of the 17 control subjects was 26.4 yr (range, 22–36 yr).

Psychological assessment

Trait measures. The following instruments were administered 3–5 days before the scheduled skydive: the MAACL-R, general form (13); the STAI, form Y-2 (12); and the SSS, form V (1). The respondents were instructed to check all the words or phrases that described how they "generally" feel.

State measures. The following instruments were administered on the control day and three times on the day of the jump: the Today form of the MAACL-R (13); form Y-1 (State form) of the STAI (12); the Subjective Stress Scale (Subj) of Kerle and Bialek (14), a list of 15 adjectives from which the subjects selected one word best describing how they felt; the Specific Rating of Events scale (SRE), in which subjects rate (on a scale of 0 for "not at all stressful" to 100 for "most stress possible") how stressed they feel "right now" or how stressful an event or time period was to them (15).

Biochemical measures

{alpha}-Amylase assay. Saliva was diluted 500-fold with 0.154 mol/L NaCl. Assay kits, obtained from Sigma Chemical Co. (St. Louis, MO), were used. They used 1.0 mmol/L 4,6-ethylidene ({alpha}-D-maltoheptaside)7-p-nitrophenyl as the substrate with 25,000 U/L {alpha}-1,4-glucan glucohydrolase (EC 3.2.1.3) in a pH 7.0 phosphate buffer containing 10 mmol/L MgCl2 and 50 mmol/L NaCl. The p-nitrophenol product was measured spectrophotometrically at 405 nm after a 2-min incubation at 37 C. The quality control for the assay was prepared from a pool of saliva that was collected from unstressed volunteers. The pool was divided into 1.0-mL aliquots and frozen in sealed vials. One vial was thawed and run with each assay. The interassay coefficient of variation (CV) of the quality control preparation was 8.5%.

Plasma cortisol. Plasma cortisol was assayed by RIA without extraction after a 1/100 dilution in 0.1 mol/L citrate, pH 4.0, buffer as performed previously (16). The interassay CV was 14%; the intraassay CV was 11% (mean, 309 nmol/L). The sensitivity of the assay at this dilution was 47 nmol/L.

Salivary cortisol. Salivary cortisol was assayed by RIA without extraction after a 1:10 dilution in 0.1 mol/L citrate buffer, pH 4.0. The antiserum and labeled cortisol were previously described (16). The interassay CV was 14%; the intraassay CV was 12% (mean, 11 nmol/L). The sensitivity of the assay at this dilution was 68 pmol/L.

Plasma PRL. Plasma PRL was assayed by RIA with materials obtained from the National Hormone and Pituitary Program of the NIDDK, NIH, at the University of Maryland according to recommendations provided with the material. The reference and iodination materials for PRL assay were NIDDK human (h) PRL RP-1 and NIDDK hPRL I-7, respectively. The antiserum was NIDDK anti-hPRL-3. The sensitivity of the assay was 2.1 ng/mL. The interassay CV was 22% (mean, 9.0 ng/mL), and the intraassay CV was 17.6% (mean, 9.1 ng/mL).

Plasma testosterone. Plasma testosterone was assayed by RIA by a direct method without extraction. Materials, including [125I]testosterone, for this procedure were obtained from Pantex (Santa Monica, CA). Antibody-bound testosterone was precipitated from solution by the addition of a second antibody in polyethylene glycol. The sensitivity of the assay (2 SD at the lowest standard) was 368 pmol/L. The interassay CV (mean, 1747 pmol/L) was 15%; the intraassay CV was 9.9%.

Salivary testosterone. Salivary testosterone was measured by RIA without extraction. Antiserum was prepared in this laboratory. Cross-reactivities with dihydrotestosterone and androstenedione were 13% and 0.2%; those for androsterone, etiocholanolone, estradiol, and dehydroepiandrosterone were all less than 0.1%. The interassay CVs were 10.5% for the low reference (0.13 nmol/L) and 16.7% for the high reference (0.40 nmol/L). The intraassay CV was 14.1%. The sensitivity was 0.028 nmol/L.

LH. LH was assayed by RIA with materials supplied by the National Hormone and Pituitary Program of the NIDDK. Iodination with 125I, purification of the iodinated hormone, and separation of the antibody-bound hormone from unbound hormone were performed as described by Midgley, Jr. (17). The interassay CV (mean, 12 mIU/mL) was 15%; the intraassay was 26%. The sensitivity of the assay was 2.4 mIU/mL.

GH. GH was assayed by RIA with materials obtained from the National Hormone and Pituitary Program, NIDDK. The standard and iodination materials were hGH RP-1 and hGH I-1, respectively. The sensitivity of the assay was 1.2 ng/mL. The interassay CV (mean, 5.2 ng/mL) was 15%; the intraassay CV was 12%.

Statistical analyses

Comparisons between the control group and skydiving group were made by ANOVA with repeated measures using the Systat statistical package for the microcomputer (Systat, Evanston, IL) (18). For this purpose there were three time intervals for the comparison, as listed in the description of the control subjects’ participation. Multiple stepwise regression with the psychological trait as dependent variable and hormones/amylase at the time of landing as the independent variables was also carried out using Systat. The significances of both the between-treatment difference and the treatment by time interaction are reported.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The subjects who volunteered for skydiving did not differ significantly from the control group in the measured personality characteristics. The results of the subscores of the MAACL-R for anxiety, hostility, and depression among first time skydivers and control subjects are shown in Table 1Go, as are the results of the STAI, Subj, and SRE instruments. The level of anxiety perceived at the beginning of the day was not significantly higher than that of the subjects themselves on the control day or that of the control subjects (data not shown) on either of the anxiety scales. However, there were significant changes in the anxiety perceived by the subjects as the time for the skydive drew near. Significant increases in the MAACL-R anxiety scale and the STAI scales were recorded shortly before the subjects entered the airplane (Table 1Go). Hostility and depression were not significantly elevated on the MAACL-R at the beginning of the day in skydivers, and no significant differences occurred in these measures during the day. The Subj was elevated relative to the control day and the early morning scores just before entering the airplane. The SRE was the only psychological measure that showed a significant increase in scores from the control day to the 0800 h assessment on the day of the skydive.


View this table:
[in this window]
[in a new window]
 
Table 1. Standardized psychological scores associated with skydiving ± SE

 
Both plasma and salivary cortisol were lower in the skydivers than in the control group at 0845 h (Figs. 1Go and 2Go). The mean plasma cortisol value in skydivers themselves on the control day (226 ± 18 nmol/L), 3–5 days before the jump, was not different from that in the control group at the same time of day. There was no anticipatory increase in cortisol; levels did not increase significantly until the skydivers landed. Cortisol levels in plasma and saliva then continued to rise over the next 15 min before starting to fall. The interaction between treatment and time was significant (P < 0.001).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Plasma cortisol was measured in blood samples obtained from an indwelling catheter throughout the day of the skydive (solid circles) at the times of day indicated on the abscissa. Control samples were taken from a similar group of subjects who were not recruited for skydiving (open circles). The first four samples in skydivers were taken at 15-min intervals on the trip from the medical center to the skydiving center. Another sample was taken just before entering the airplane for the skydive (arrow on the graph). Four additional samples were taken at 15-min intervals beginning the moment the volunteers touched the ground after the skydive.

 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Salivary cortisol was measured in specimens obtained from each subject at the same times that the blood samples were obtained (solid circles). Control specimens were obtained from volunteers who were not recruited for skydiving (open circles). The intervals are described in Fig. 1Go. Note the similarity between the plasma and salivary patterns.

 
Salivary amylase concentrations, a measure of the response to catecholamines (16), were significantly higher in the skydivers on the morning of the jump than in the control group (P < 0.001; Fig. 3Go). However, amylase levels in the subjects themselves on the control day (369 ± 44 U/mL) were similar to the levels on the morning of the jump.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Salivary {alpha}-amylase was measured in all saliva specimens from skydiving volunteers (solid circles) and from control subjects (open circles). Note that the levels throughout the day were higher in the subjects who had volunteered to skydive than in the control subjects who were not recruited for skydiving, and that the highest levels measured were at the time of landing.

 
Plasma PRL concentrations in skydivers were significantly lower than those in controls at the three time points at which both were measured (P < 0.012), and the interaction was significant (Fig. 4Go). As with amylase levels, plasma PRL levels on the morning of the jump were not lower than those on the control day (7.3 ± 0.6 ng/mL) in subjects who volunteered to skydive, but were slightly lower than those in the control group. Plasma PRL levels in skydivers greatly exceeded preflight and control levels upon landing (P < 0.01).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 4. Plasma PRL was measured in blood specimens using the regimen described for Fig. 1Go. No significant increase in PRL occurred during the preflight period.

 
GH was significantly higher in skydivers (P < 0.013) across the three time points and was maintained at high levels for a longer period after landing than were amylase or PRL levels (Fig. 5Go). The mean level on the control day (2.0 ± 0.4) was similar to that in the control group at the same time of day. There was no significant interaction with time.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. Plasma GH was measured in blood specimens using the regimen described in Fig. 1Go. GH did not increase during the preflight period.

 
Plasma testosterone was not different in skydivers and control subjects (Fig. 6Go). The mean value in skydivers on the control day was 19.3 ± 1.3 nmol/L, slightly higher but similar to that in the control group at the same time of day. It tended to be lower upon entering the plane, but the ANOVA with repeated measures was not significant. On the other hand, salivary testosterone concentrations were significantly lower by ANOVA throughout the day (P < 0.001), particularly at the time just before boarding the plane (Fig. 7Go). The mean salivary testosterone value in skydivers on the control day was higher (0.36 ± 0.03 nmol/L) than the mean value in the control group at the same time of day. Thus, the suppression may have been even greater than that between the control group and the skydivers.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 6. Plasma testosterone, measured in blood samples obtained using the regimen described in Fig. 1Go, was not significantly different from control values at any time during the day.

 


View larger version (17K):
[in this window]
[in a new window]
 
Figure 7. Salivary testosterone, measured in saliva obtained using the regimen described in Fig. 2Go, was significantly lower in skydivers than in control subjects. This was particularly evident at the time just before entering the airplane for the skydive.

 
Plasma LH levels were higher in skydivers than in controls (P < 0.05), and the mean value on the control day (5.7 ± 0.4 mIU/mL) was similar to that in the control group (Fig. 8Go). No significant interaction with the control group occurred at the times when control samples were collected.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 8. Plasma LH, measured in blood samples obtained using the regimen described in Fig. 1Go, was not lower in skydivers than in controls and was increased in samples obtained from subjects after landing.

 
Hormones and amylase at landing were regressed on each of the psychological measures to determine the potential relationships. To avoid entering correlated cortisol and testosterone values twice, only the salivary values were used in the regression. Stepwise multiple regressions were determined for all psychological measures obtained on the control day in skydivers against independent hormonal and amylase measures obtained on the day of skydiving (immediately upon landing). Significant regressions with hormones and amylase as independent variables were found for the STAI (State form), the SSS, and the SRE (Table 2Go). PRL was a significant component of the regressions in each case, but in one case it was negative, and in the others it was positive. The only other hormones that contributed significantly to the regressions were testosterone and cortisol. The relationships were not improved when the psychological state measures were evaluated against the same hormonal variables.


View this table:
[in this window]
[in a new window]
 
Table 2. Summary of the stepwise multiple regression analyses

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The lack of an increase in reported anxiety or subjective stress early on the morning of skydiving was unexpected. Only the SRE showed a significant increase early on the day of the skydive. The latter is in accord with comments made by the subjects to the investigators about their concerns about the safety of the skydive. Equally surprising, but consistent with the shorter period evaluated by Richter et al. (7), was the finding that none of the hormone levels increased significantly during the 4-h period between the early morning blood sample and the sample taken just before entering the airplane. However, amylase levels in saliva were highly significantly elevated at the time of the first sample on the experimental day compared with those in the control group and remained elevated, with highest levels at the time of landing. This is similar to previous findings on urinary catecholamines (19) and plasma norepinephrine levels (7) in parachutists. Both studies revealed significant increases between control levels and those measured hours before the jump. Salivary amylase, an enzyme secreted in response to activation of the sympathetic nervous system (16), provided similar data, further validating this end point as a means of assessing catecholamine responses. The rapidity of the changes in catecholamines and amylase is illustrated by the 40% decline in amylase concentrations in saliva between the sample collected immediately upon landing and the sample collected 15 min later. This further demonstrates the utility of frequent saliva samples as a noninvasive method for assessment of plasma catecholamines.

The low levels of plasma cortisol in the morning before the jump were also unexpected. Previous studies (4, 5, 7) did not compare basal levels with prejump levels on the day of parachuting. Nevertheless, Levine et al. (5) have made the argument that when an individual is coping with stress, there is little or no elevation in plasma cortisol. For example, a situation has been described in which soldiers waiting for an enemy attack had lower than normal glucocorticoid production, whereas the responsible officers had high levels (20). Similarly, radio officers on planes involved in practice landings on aircraft carriers did not have elevated urinary glucocorticoids, but the pilots who were conducting the landings did, despite the fact that the radio officers were as much at risk as the pilots (11). In the present study it may be assumed that the subjects who volunteered to skydive were coping, at least until the actual event. The fact that they were jumping while attached to an experienced instructor relieved them of the responsibility for their own safety, much as the soldiers and radio officers were relieved. Nevertheless, experiencing the actual sensation of falling was evidently more than their coping mechanisms were prepared to handle. This is similar to the situation faced by patients waiting for surgery. In the study of Czeisler et al. (10), patients had no increase in plasma cortisol until the actual physical preparation for surgery was conducted. During surgical preparations, denial of the impending procedure may have been impossible, causing coping mechanisms to fail and plasma cortisol levels to increase greatly.

In the present study measurements of salivary cortisol reflected the plasma levels, as has been shown in previous studies (21, 22), suggesting that salivary measures can be satisfactorily substituted for plasma assays of cortisol.

PRL levels have been shown in some studies to be increased by anxiety. This has been shown to occur in students about to take an examination (23, 24), although there is not complete agreement on this (25). In the present study the high levels of anxiety expressed just before entering the airplane were associated with a subsequent surge in plasma PRL concentrations. It is clear in this study that anxiety preceded the rise in plasma PRL levels. Generally, plasma PRL levels paralleled those of cortisol, except that the PRL response to the jump was more rapid than that of cortisol. PRL had reached peak values by the time of landing or before, as shown previously (8), whereas cortisol had not yet reached a peak upon landing. The observation that the group who had volunteered to skydive had significantly higher levels of amylase 3–5 days before the day of the skydive is interesting and must be evaluated further. It cannot be determined whether these subjects had a higher than normal level persistently, or if the anticipation of the skydive produced an effect at the time when the control sample was taken.

Plasma GH was generally increased, but not uniformly among individuals, by the skydiving stressor. Shedlowski et al. (4) also examined the change in plasma GH from shortly before to immediately after parachuting and found no difference; Richter et al. (7) found a small, but significant, increase. In the study of Weitzman et al. (26) when the plasma GH level after parachuting was compared with that on a control day, a rather large increase was seen. Our data are consistent with these studies. The increase from immediately before the jump to immediately after was not significant, but when comparing the GH concentrations in control subjects with the levels after the jump, the increase was significant.

Plasma testosterone levels were not different from those in controls before the jump and were not greatly decreased at the time of landing. However, the difference in the salivary concentrations of testosterone in the same subjects was remarkable. The skydivers appeared to have a decrease in salivary testosterone as the time for boarding the airplane approached. After the jump, a fairly complex pattern appeared: a small rise upon landing when the other hormones were rising, and then a fall. Nevertheless, the precision of the pattern after landing cannot be established from a single study. The failure to find a significant decrease in plasma testosterone levels may reflect a change in the unbound fraction. This must be investigated further. However, the changes in concentration cannot be attributed to dilution effects, as the concentration of salivary cortisol, measured in the same specimens, did not change during the time when testosterone levels declined.

An anticipatory decline in salivary testosterone has not been reported previously to our knowledge, although many studies have shown that testosterone declines after a stressful event. Ghanadian et al. (6), measuring testosterone before and after surgery in men, found that by comparison with levels 2 days before surgery, the lowest levels were found 2 days after surgery (70% decrease); complete recovery required a month. Shorter intervals were not studied. In addition, in a study of acute responses to exercise, plasma testosterone was found to be increased immediately after an exercise regimen; 2 h later there was a significant decrease, which persisted for more than 8 h (27). The results of the latter study appear to be similar to those we observed after the subjects had landed. Nevertheless, the prejump suppression that was evident from the salivary testosterone measurements demonstrates a purely psychological cause of the decrease in testosterone.

Although not conclusive because of the sampling frequency, the finding that plasma LH was elevated after the skydive suggests that the cause of the suppression of testosterone secretion was not the result of a decrease in gonadotropin stimulation, but may be the result of a direct action on the testis.

As administration of cortisol has been shown to suppress plasma testosterone levels in men (28), it may be presumed that cortisol is responsible for the decline in testosterone in the present study. However, this cannot be the explanation, because the decrease in testosterone occurred during the time when plasma cortisol levels were suppressed. The mechanism by which a psychological stressor inhibits testosterone secretion in man is an interesting observation that should be investigated further.

In an attempt to determine whether there is an association between personality traits and hormone responses, a stepwise multiple regression was performed. Highly significant relationships were found for the STAI, the SSS, and the SRE measured 3–5 days before the skydive and hormones measured immediately after the skydive. For the latter scale, 44% of the variability could be attributed to salivary testosterone and plasma PRL. Inclusion of other hormonal variables or amylase did not increase the closeness of this relationship. Surprisingly, measures of the psychological state on the day of skydiving could not be predicted with greater precision from concurrent hormone levels than could the psychological trait scores. The precise relationships cannot be determined with confidence from a single study of this magnitude, but this may be a fruitful avenue of future investigation.

In summary, as indicated by the low levels of cortisol and the low reported levels of anxiety on standardized psychological instruments, the subjects were coping with the situation early on the morning of the jump. However, within minutes before entering the airplane, it is apparent that personal defenses broke down, anxiety and subjective stress levels rose, and the low to normal levels of cortisol, amylase, PRL, and GH increased rapidly to very high levels. We conclude that the process of coping with anxiety and fear in this situation is characterized in men by specific hormone patterns, particularly elevated catecholamines and suppressed levels of cortisol and testosterone.


    Footnotes
 
1 This work was supported by a contract with the U.S. Army Human Engineering Laboratory, Aberdeen Proving Ground (Aberdeen, MD; DAAA15–90-C-1049). Back

Received February 28, 1997.

Revised April 15, 1997.

Accepted April 23, 1997.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Zuckerman M, Kolin EA, Price L, Zoob I. 1964 Development of a sensation-seeking scale. J Consult Psychol. 28:477–482.[CrossRef][Medline]
  2. Levine S, Weinberg J, Ursin H. 1978 Definition of the coping process and statement of the problem. In: Ursin H, Baade E, Levine S, eds. Psychobiology of stress. A study of coping men. New York: Academic Press; 3–20.
  3. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. 1994 Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci USA. 91:10440–10444.[Abstract/Free Full Text]
  4. Schedlowski M, Wiechert D, Wagner TOF, Tewes U. 1992 Acute psychological stress increases plasma levels of cortisol, prolactin and TSH. Life Sci. 50:1201–1205.[CrossRef][Medline]
  5. Levine S. 1978 Cortisol changes following repeated experiences with parachute training. In: Ursin H, Baade E, Levine S, eds. Psychobiology of stress. A study of coping men. New York: Academic Press; 51–55.
  6. Ghanadian R, Puah CM, Williams G, Shah PJR, McWhinney N. 1981 Suppressive effects of surgical stress on circulating androgens during and after prostatectomy. Br J Urol. 53:147–149.[Medline]
  7. Richter SD, Schurmeyer TH, Schedlowski M, et al. 1996 Time kinetics of the endocrine response to acute psychological stress. J Clin Endocrinol Metab. 81:1956–1960.[Abstract]
  8. Noel GL, Dimond RC, Earll JM, Frantz AG. 1976 Prolactin, thyrotropin, and growth hormone release during stress associated with parachute jumping. Avait Space Environ Med. 47:543–547.
  9. Mills FJ. 1985 The endocrinology of stress. Aviat Space Environ Med. 56:642–650.[Medline]
  10. Czeisler CA, Moore Ede MC, Regenstein QR, et al. 1976 24-hour cortisol secretory patterns in patients awaiting elective cardiac surgery. J Clin Endocrinol Metab. 42:273–283.[Abstract/Free Full Text]
  11. Miller RG, Rubin RT, Clark BR, Crawford WR, Arthur RJ. 1970 The stress of aircraft carrier landings. Psychosom Med. 32:581–588.[Abstract/Free Full Text]
  12. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. 1983 Manual for the State-Trait Anxiety Inventory (form Y). Palo Alto: Consulting Psychologists Press.
  13. Zuckerman M, Lubin B. 1985 Manual for the MAACL-R: Multiple Affect Adjective Checklist (revised). San Diego: Educational and Industrial Testing Service.
  14. Kerle RH, Bialek HM. 1958 The construction, validation, and application of a subjective stress scale. Staff memorandum, U.S. Army Leadership Human Research Unit, Presidio of Monterey, Fighter IV, Study 23; 1–6.
  15. Fatkin LT, Hudgens GA, Torre Jr JP, King JM, Chatterton Jr RT. 1991 Psychological responses to competitive marksmanship. In: Torre Jr JP, Wansack S, Hudgens GA, et al., eds. Effects of competition, and mode of fire on physiological responses, psychological stress reactions, and shooting performance. Technical memorandum 11–91. Aberdeen: U.S. Army Human Engineering Laboratory, Aberdeen Proving Ground; 000–000
  16. Chatterton Jr RT, Vogelsong KM, Lu Y-C, Ellman AB, Hudgens GA. 1996 Salivary {alpha}-amylase as a measure of endogenous adrenergic activity. Clin Physiol. 16:433–448.[Medline]
  17. Midgley Jr AR. 1966 Radioimmunoassay: a method for human chorionic gonadotropin, and human luteinizing hormone. Endocrinology. 79:10–18.[Abstract/Free Full Text]
  18. Wilkinson L. 1996 Systat 6.0 for Windows. Chicago: SPSS; 122–221.
  19. Hansen JR, Stoa KF, Schytte Blix A, Ursin H. 1978 Urinary levels of epinephrine and norepinephrine in parachutist trainees. In: Ursin H, Baade E, Levine S, eds. Psychobiology of stress. A study of coping men. New York: Academic Press; 63–74.
  20. Bourne PG, Rose RM, Mason JW. 1968 17-OHCS levels in combat. Arch Gen Psychiatry. 19:135–140.[Abstract/Free Full Text]
  21. Katz FH, Shannon JL. 1969 Parotid fluid cortisol and cortisone. J Clin Endocrinol Metab. 48:848.[Abstract/Free Full Text]
  22. Tunn S, Möllmann H, Barth J, Derendorf H, Krieg M. 1992 Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration. Clin Chem. 38:1491–1494.[Abstract/Free Full Text]
  23. Hudgens GA, Chatterton Jr RT, Torre Jr J, et al. 1988 Hormonal and psychological profiles in response to a written examination. In: Zinder O, Bresnitz S, eds. Molecular biology of stress. UCLA Symposia on Molecular and Cellular Biology, New Series, vol 97. New York: Liss; 265–275.
  24. Herbert J, Moore GF, de la Riva C, Watts FN. 1986 Endocrine responses and examination anxiety. Biol Psychol. 22:215–226.[CrossRef][Medline]
  25. Semple CG, Gray CE, Borland W, Espie CA, Beastall GH. 1988 Endocrine effects of examination stress. Clin Sci. 74:255–259.[Medline]
  26. Weitzman ED, Ursin H. 1978 Growth hormone. In: Ursin H, Baade E, Levine S, eds. Psychobiology of stress. A study of coping men. New York: Academic Press; 91–97.
  27. Fry RW, Morton AR, Garcia-Webb P, Keast D. 1991 Monitoring exercise stress by changes in metabolic and hormonal responses over a 24-h period. Eur J Appl Physiol. 63:228–234.[CrossRef]
  28. Cumming DC, Quigley ME, Yen SS. 1983 Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab. 57:671–673.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Holist NursHome page
K. G. Mellott, P. B. Sharp, and L. M. Anderson
Biobehavioral Measures in a Critical-Care Healing Environment
J Holist Nurs, June 1, 2008; 26(2): 128 - 135.
[Abstract] [PDF]


Home page
J EndocrinolHome page
R. T Chatterton Jr, J. Zujewski, E. T Mateo, J. Eng-Wong, and V C. Jordan
Effect of raloxifene on salivary sex steroid concentrations in premenopausal women
J. Endocrinol., December 1, 2006; 191(3): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
U. Ehlert, K. Erni, G. Hebisch, and U. Nater
Salivary {alpha}-Amylase Levels after Yohimbine Challenge in Healthy Men
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5130 - 5133.
[Abstract] [Full Text] [PDF]


Home page
Journal of Social and Personal RelationshipsHome page
D. A. Granger, K. T. Kivlighan, C. Blair, M. El-Sheikh, J. Mize, J. A. Lisonbee, J. A. Buckhalt, L. R. Stroud, K. Handwerger, and E. B. Schwartz
Integrating the measurement of salivary {alpha}-amylase into studies of child health, development, and social relationships
Journal of Social and Personal Relationships, April 1, 2006; 23(2): 267 - 290.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Nierop, A. Bratsikas, A. Klinkenberg, U. M. Nater, R. Zimmermann, and U. Ehlert
Prolonged Salivary Cortisol Recovery in Second-Trimester Pregnant Women and Attenuated Salivary {alpha}-Amylase Responses to Psychosocial Stress in Human Pregnancy
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1329 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Axelsson, T. Akerstedt, G. Kecklund, A. Lindqvist, and R. Attefors
Hormonal changes in satisfied and dissatisfied shift workers across a shift cycle
J Appl Physiol, November 1, 2003; 95(5): 2099 - 2105.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. Bergmann, S. Huber, H. Machler, E. Liebl, H. Hinghofer-Szalkay, P. Rehak, and B. Rigler
The Influence of Medical Information on the Perioperative Course of Stress in Cardiac Surgery Patients
Anesth. Analg., November 1, 2001; 93(5): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
C. A. Morgan III, S. Wang, A. Rasmusson, G. Hazlett, G. Anderson, and D. S. Charney
Relationship Among Plasma Cortisol, Catecholamines, Neuropeptide Y, and Human Performance During Exposure to Uncontrollable Stress
Psychosom Med, May 1, 2001; 63(3): 412 - 422.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. Garg, M.-M. Chren, L. P. Sands, M. S. Matsui, K. D. Marenus, K. R. Feingold, and P. M. Elias
Psychological Stress Perturbs Epidermal Permeability Barrier Homeostasis: Implications for the Pathogenesis of Stress-Associated Skin Disorders
Arch Dermatol, January 1, 2001; 137(1): 53 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. T. Chatterton Jr., P. D. Hill, J. C. Aldag, K. R. Hodges, S. M. Belknap, and M. J. Zinaman
Relation of Plasma Oxytocin and Prolactin Concentrations to Milk Production in Mothers of Preterm Infants: Influence of Stress
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3661 - 3668.
[Abstract] [Full Text]


Home page
Biol Res NursHome page
P. D. Hill, R. T. Chatterton Jr., and J. C. Aldag
Serum Prolactin in Breastfeeding: State of the Science
Biol Res Nurs, July 1, 1999; 1(1): 65 - 75.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
L. P. Koziris, R. C. Hickson, R. T. Chatterton Jr., R. T. Groseth, J. M. Christie, D. G. Goldflies, and T. G. Unterman
Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training
J Appl Physiol, April 1, 1999; 86(4): 1436 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
R. T. Chatterton Jr. and S. L. Dooley
Reversal of Diurnal Cortisol Rhythm and Suppression of Plasma Testosterone in Obstetric Residents on Call
Reproductive Sciences, January 1, 1999; 6(1): 50 - 54.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Schedlowski and T. O. F. Wagner
Psychological Stress and Sky Diving--Authors' Responsec
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1397 - 1397.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Dugué, E. Leppänen, and R. Gräsbeck
Psychological Stress and Skydivingb
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1396a - 1397.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. T. Chatterton
Psychological Stress and Skydiving--Author's Responsed
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1397a - 1398.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chatterton, R. T.
Right arrow Articles by Hudgens, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatterton, R. T., Jr.
Right arrow Articles by Hudgens, G. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals